Clinical manifestations of dual‐gene variants in retinitis pigmentosa
Acta Ophthalmologica · 26.06.2026
DOI: 10.1111/aos.70181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ophthalmologica, online erschienen am 26.06.2026. Verfasst von Lasse Wolfram und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department for Ophthalmology, University Eye Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Retinitis pigmentosa (RP) is an inherited retinal disease (IRD), whereby each affected individual typically harbours pathogenic variants in a single causative gene, yet the disorder exhibits marked genetic heterogeneity, with more than 100 genes reported to underlie RP. Dual‐gene defect constellations are rare but may modify disease presentation, complicating diagnosis, prognosis and therapeutic decision‐making. This study aimed to characterize the clinical and genetic effects of dual‐gene variants in patients with RP as the lead diagnosis.
Methods
We retrospectively analysed 10 affected individuals and their parents from eight families with confirmed dual‐genotype constellations in RP‐associated genes. Ophthalmic evaluation included best‐corrected visual acuity (BCVA), visual fields, multimodal imaging, electroretinography (ERG) and full‐field stimulus threshold testing (FST). Genetic analyses comprised whole genome sequencing and targeted segregation studies; for the latter, long‐read sequencing was used to clarify cis/trans variant configuration.
Results
Genes involved were CEP290 , RCBTB1 , ABCA4 , PDE6A , CRB1 , EYS , PRPH2 , MYO7A , RS1 , USH2A , MT‐TL1 , RHO and BEST1 , in various genotype constellations. Phenotypes ranged from early‐onset severe rod‐cone dystrophy to late‐onset mild RP, largely reflecting gene‐specific effects (e.g. EYS > CRB1 > PRPH2 ) and their interactions. Long‐read sequencing revealed ABCA4 variants in cis , explaining asymptomatic carriers and informing gene therapy eligibility. Functional retinal testing highlighted gene‐specific patterns, including macular preservation in EYS ‐driven RP and Best disease‐associated macular changes.
Conclusion
Dual‐gene variant constellations contribute to heterogeneous RP phenotypes. Integrating comprehensive genetic analysis with detailed clinical assessment is critical to define gene‐specific contributions, inform prognosis, guide clinical management and determine eligibility for emerging gene‐based therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Ophthalmology, University Eye Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Department for Ophthalmology, Institute for Ophthalmic Research, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Center for Rare Eye Diseases, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Institute of Medical Genetics and Applied Genomics, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Center for Rare Disease, Eberhard Karls University of Tübingen, Tübingen, Germany.
ORCID-Profile: Lasse Wolfram, Jan-Philipp Bodenbender, David A Merle, Anton Sonntag
Zitieren
APA
Wolfram, L., Bodenbender, J. P., Merle, D. A., Reith, M., Sonntag, A., Stingl, K., Haack, T. B., Zuleger, T., Wissinger, B., Kühlewein, L., Stingl, K., & Kohl, S. (2026). Clinical manifestations of dual‐gene variants in retinitis pigmentosa. Acta Ophthalmologica. https://doi.org/10.1111/aos.70181
Vancouver
Wolfram L, Bodenbender JP, Merle DA, Reith M, Sonntag A, Stingl K, et al. Clinical manifestations of dual‐gene variants in retinitis pigmentosa. Acta Ophthalmologica. 2026. doi:10.1111/aos.70181
BibTeX
@article{Wolfram2026,
author = {Wolfram, Lasse and Bodenbender, Jan-Philipp and Merle, David A and Reith, Milda and Sonntag, Anton and Stingl, Krunoslav and Haack, Tobias B and Zuleger, Theresia and Wissinger, Bernd and Kühlewein, Laura and Stingl, Katarina and Kohl, Susanne},
title = {Clinical manifestations of dual‐gene variants in retinitis pigmentosa},
journal = {Acta Ophthalmologica},
year = {2026},
doi = {10.1111/aos.70181}
}
EUVIMED